F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$53.62M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.24M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	477
Open	24.32
Previous Close	24.03
Day's Range	24.32 - 24.43
52-Week Low	18.78
52-Week High	27.76
Beta	n/a
Holdings	34
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

57.58% of assets

Name	Symbol	Weight
Soleno Therapeutics, Inc.	SLNO	7.42%
BridgeBio Pharma, Inc.	BBIO	7.34%
TransMedics Group, Inc.	TMDX	6.50%
RadNet, Inc.	RDNT	6.42%
LivaNova PLC	LIVN	6.14%
Blueprint Medicines Corporation	BPMC	6.08%
Merit Medical Systems, Inc.	MMSI	4.95%
Travere Therapeutics, Inc.	TVTX	4.30%
Collegium Pharmaceutical, Inc.	COLL	4.30%
89bio, Inc.	ETNB	4.13%